Table 4

PC and OGC module data from pilot data collection

VariablePC moduleOGC module
n (%)n (%)
Recruited 115 180
 Recruited via invitation letter88 (76.5)120 (66.7)
 Recruited via waiver of consent (deceased)27 (23.5)60 (33.3)
Sex
 Male56 (48.7)132 (73.3)
 Female59 (51.3)48 (26.7)
Age at diagnosis (years)
 <506 (5.2)11 (6.1)
 50–5914 (12.2)22 (12.2)
 60–6930 (26.1)54 (30.0)
 70–7938 (33.0)54 (30.0)
 ≥8022 (19.1)33 (18.3)
 Missing5 (4.3)6 (3.3)
Resectability at diagnosis
 Resectable25 (21.7)58 (32.2)
 Borderline resectable3 (2.6)11 (6.1)
 Unresectable67 (58.3)64 (35.6)
Locally advanced (LA) 24 (20.9) 6 (3.3)
Metastatic (Mets) 43 (37.4) 58 (32.2)
 Not documented14 (12.2)
 Unknown41 (22.8)
 Missing6 (5.2)6 (3.3)
Clinical stage at diagnosis
 I or II5 (4.3)33 (18.3)
 III7 (3.9)
 IV18 (15.7)50 (27.8)
 Complete TNM* not documented80 (69.6)82 (45.6)
 Missing12 (10.4)8 (4.4)
First treatment
 Neoadjuvant therapy4 (3.5)60 (33.3)
 Attempted or completed resection surgery27 (23.5)13 (7.2)
 Curative intent ChemoTx and/or RT7 (3.9)
 Palliative intent ChemoTx and/or RT37 (32.2)55 (30.6)
 No treatment29 (25.2)23 (12.8)
 Unknown16 (8.9)
 Missing18 (15.7)6 (3.3)
Reasons for no surgery†
 LA or Mets6260
 Advanced age16
 Comorbidities79
 Patient declined112
 Patient died prior to surgery07
 Performance status4
 Other reason1
 Reason not documented43
Participant data collection status
 Complete51 (44.3)107 (59.4)
 Incomplete64 (55.7)73 (40.6)
Data entry subform completeness
 Demographics113 (98.2)180 (100.0)
 Vital status and tumour recurrence58 (50.4)145 (80.6)
 Diagnosis details97 (84.3)165 (91.7)
 Biliary stents94 (81.7)
 Surgery102 (88.7)168 (93.3)
 Pathology of resection sample102 (88.7)
 Neoadjuvant therapy104 (90.4)
 Adjuvant therapy98 (85.2)
 Therapy for locally advanced disease95 (82.6)
 Therapy for metastatic disease77 (67.0)
 Other treatment and trials80 (70.0)
 Treatment summary167 (92.8)
 Restaging after neoadjuvant therapy167 (92.8)
 Chemotherapy details162 (90.0)
 Radiotherapy details163 (90.6)
 End-of-life details81 (45.0)
  • *TNM system of classification of cancer.

  • †Reason for no surgery: participants may have more than one reason documented.

  • ChemoTX, chemotherapy; RT, radiotherapy.